The use of LMWH in pregnancies at risk: new evidence or perception?
- 1 April 2005
- journal article
- editorial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 3 (4) , 778-779
- https://doi.org/10.1111/j.1538-7836.2005.01286.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The long and winding road ... towards LMWH for pregnancy lossJournal of Thrombosis and Haemostasis, 2005
- Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?Journal of Thrombosis and Haemostasis, 2005
- Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE‐ENOX studyJournal of Thrombosis and Haemostasis, 2004
- Use of Antithrombotic Agents During PregnancyChest, 2004
- Antiphospholipid Syndrome in PregnancyObstetrics & Gynecology, 2002
- Antiphospholipid Syndrome in PregnancyObstetrics & Gynecology, 2002
- How strong is the association between maternal thrombophilia and adverse pregnancy outcome?European Journal of Obstetrics & Gynecology and Reproductive Biology, 2002
- Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)BMJ, 1997
- Antiphospholipid antibody–associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin aloneAmerican Journal of Obstetrics and Gynecology, 1996
- A Clinical Trial for the Treatment of Antiphospholipid Antibody‐Associated Recurrent Pregnancy Loss With Lower Dose Heparin and AspirinAmerican Journal of Reproductive Immunology, 1996